JP2000229944A - Production of 6-hydroxy-2-oxo-1,2,3,4-terrahydroquinoline - Google Patents
Production of 6-hydroxy-2-oxo-1,2,3,4-terrahydroquinolineInfo
- Publication number
- JP2000229944A JP2000229944A JP11108016A JP10801699A JP2000229944A JP 2000229944 A JP2000229944 A JP 2000229944A JP 11108016 A JP11108016 A JP 11108016A JP 10801699 A JP10801699 A JP 10801699A JP 2000229944 A JP2000229944 A JP 2000229944A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- oxo
- tetrahydroquinoline
- general formula
- producing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
- B01J27/00—Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
- B01J27/06—Halogens; Compounds thereof
- B01J27/08—Halides
- B01J27/10—Chlorides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
- C07C233/24—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
- C07C233/27—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明はシロスタゾル(Cilo
stazol)の合成中間体として有用な6−ヒドロキシ−2
−オキソ−1,2,3,4−テトラヒドロキノリンを製
造する方法に関する。TECHNICAL FIELD The present invention relates to cilostazol (Cilosol).
6-Hydroxy-2 useful as a synthetic intermediate for stazol)
-Oxo-1,2,3,4-tetrahydroquinoline.
【0002】[0002]
【従来の技術】シロスタゾルは血栓治療剤として使われ
ており、その化学名は6−[4−(1−シクロヘキシル
−5−テトラゾリル)ブトキシ]−1,2,3,4−テト
ラヒドロ−2−オキソキノリンであり、構造式は下記一
般式(V)で表される。2. Description of the Related Art Cilostazol is used as a therapeutic agent for thrombosis, and its chemical name is 6- [4- (1-cyclohexyl-5-tetrazolyl) butoxy] -1,2,3,4-tetrahydro-2-oxo. It is quinoline, and its structural formula is represented by the following general formula (V).
【化5】 Embedded image
【0003】上記の一般式(V)のシロスタゾルは、合
成中間体である一般式(I)で表される6−ヒドロキシ
−2−オキソ−1,2,3,4−テトラヒドロキノリン
と5−ハロブチル−1−シクロヘキシルテトラゾルを反
応させることにより製造できる(Chem. Pharm. Bull. 3
1, 1151-1157(1983))。[0003] The cilostazol represented by the general formula (V) is a synthetic intermediate of 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline represented by the general formula (I) and 5-halobutyl. -1-cyclohexyltetrasol can be produced (Chem. Pharm. Bull. 3
1, 1151-1157 (1983)).
【0004】一般式(I)の化合物と構造が類似してい
る一般式(VII)の化合物を製造する方法が報告されて
いる(Ber. 60, 858-864(1927))。この方法によれ
ば、下記反応式に示すように、一般式(VII)で表され
る化合物は一般式(VI)のN−(4−置換−ベンゾ)−
3−クロロプロピオニルアミドを酸触媒である塩化アル
ミニウムの存在下、溶融状態で環化させることにより製
造される。A method for producing a compound of the general formula (VII) having a structure similar to that of the compound of the general formula (I) has been reported (Ber. 60, 858-864 (1927)). According to this method, as shown in the following reaction formula, the compound represented by the general formula (VII) is converted to a N- (4-substituted-benzo)-
It is produced by cyclizing 3-chloropropionylamide in the molten state in the presence of an acid catalyst, aluminum chloride.
【化6】 (式中、Xは水素原子、塩素原子、アミノ基、フェニル
基、メチル基、またはエトキシ基である。)Embedded image (In the formula, X is a hydrogen atom, a chlorine atom, an amino group, a phenyl group, a methyl group, or an ethoxy group.)
【0005】この方法は、溶媒を使わず、塩化アルミニ
ウムと一般式(VI)の化合物をかなりの高温(200〜240
℃)で反応させるために、特殊な装置を必要とする。ま
た、均等に反応させることが難しいため、収率が低く不
経済であり、危険性を伴うという欠点を有する。In this method, aluminum chloride and a compound of the general formula (VI) are used at a rather high temperature (200 to 240) without using a solvent.
C), special equipment is required. In addition, since it is difficult to make the reaction uniform, the yield is low and uneconomical, and there is a disadvantage that it involves danger.
【0006】一般式(I)の化合物は、ニトロケイ皮酸
誘導体を経由して製造することもできる(Journal of
the American Chemical Society, 66,1442-1443
(1944))。具体的には、下記反応式に示すように、一般
式(X)で表される5−ヒドロキシ−2−ニトロケイ皮
酸アルキルを還元及び環化することによって一般式
(I)の化合物が得られる。The compounds of the general formula (I) can also be prepared via nitrocinnamic acid derivatives (Journal of
the American Chemical Society, 66, 1442-1443
(1944)). Specifically, as shown in the following reaction formula, the compound of the general formula (I) is obtained by reducing and cyclizing the alkyl 5-hydroxy-2-nitrocinnamate represented by the general formula (X). .
【化7】 (式中、Rは水素原子、メチル基、またはエチル基であ
る。)Embedded image (In the formula, R is a hydrogen atom, a methyl group, or an ethyl group.)
【0007】この方法において、出発物質である一般式
(VIII)の5−ヒドロキシ−2−ニトロベンズアルデヒ
ド及び一般式(IX)の3−ヒドロキシケイ皮酸アルキル
が非常に高価であり、また、加圧条件で反応させるので
爆発の危険性がある。さらに、加水素反応では圧縮され
た気体を扱うため、特殊な装置が必要であり、発火の危
険性が非常に大きい水素を用いるため、工業化が難しい
という欠点がある。。In this process, the starting materials, 5-hydroxy-2-nitrobenzaldehyde of the general formula (VIII) and alkyl 3-hydroxycinnamate of the general formula (IX), are very expensive, There is a danger of explosion because it reacts under conditions. Furthermore, in the hydrogenation reaction, a special device is required in order to handle a compressed gas, and there is a disadvantage that industrialization is difficult because hydrogen having a very high risk of ignition is used. .
【0008】また、ケイ皮酸誘導体を用いて一般式
(I)の化合物を製造する方法が知られている(Journal
of the American Chemical Society, 89,7131-7
132 (1962))。この方法においては、下記反応式に示す
ように、一般式(I)の化合物は一般式(XIII)の3−
ヒドロキシシンナモヒドロキサム酸を環化することによ
って製造される。A method for producing a compound of the general formula (I) using a cinnamic acid derivative is also known (Journal
of the American Chemical Society, 89, 7131-7
132 (1962)). In this method, as shown in the following reaction formula, the compound of the general formula (I) is a compound of the general formula (XIII)
Produced by cyclizing hydroxycinnamohydroxamic acid.
【化8】 Embedded image
【0009】この方法は、出発物質である一般式(XI)
の3−(3−ヒドロキシフェニル)プロピオン酸が非常
に高価であること及び出発物質から三段階の反応工程が
必要であるため非効率的であり、最終生産物の収率が52
%と低いことが欠点である。The process comprises the steps of starting a compound of general formula (XI)
3- (3-hydroxyphenyl) propionic acid is inefficient due to the very high cost and the need for three reaction steps from the starting material, resulting in a final product yield of 52%.
% Is a disadvantage.
【0010】また、一般式(I)の化合物と構造が類似
している一般式(XVI)で表される化合物を下記反応式
に従って製造する方法が知られている(Journal of t
he Organic Chemistry, 36, 3975-3979 (1971))。こ
の方法においては、一般式(XIV)の4−置換−アクリ
ルアニリドを環化して一般式(XV)の化合物を合成し、
これを脱アルキル化することによって一般式(XVI)で
表される6−ヒドロキシ−3−置換−4−ヒドロカルボ
スチリルが製造される。A method is also known for producing a compound represented by the general formula (XVI) having a similar structure to the compound of the general formula (I) according to the following reaction formula (Journal of t.
he Organic Chemistry, 36, 3975-3979 (1971)). In this method, a compound of the general formula (XV) is synthesized by cyclizing a 4-substituted-acrylanilide of the general formula (XIV),
This is dealkylated to produce 6-hydroxy-3-substituted-4-hydrocarbostyril represented by the general formula (XVI).
【化9】 (式中、Rは水素原子、メチル基またはエチル基であ
り、R1はアルキル基または電子供与基である。)Embedded image (In the formula, R is a hydrogen atom, a methyl group or an ethyl group, and R 1 is an alkyl group or an electron donating group.)
【0011】この方法は、一般式(XV)の化合物を製造
する際、工業的に不適切な光反応を行うこと及びその収
率が13%と非常に低い点で問題がある。This method has a problem in that, when the compound of the general formula (XV) is produced, an industrially inappropriate photoreaction is performed and the yield is as low as 13%.
【0012】[0012]
【発明が解決しようとする課題】本発明は、工業的に安
全かつ簡便で、安価に、収率よく6−ヒドロキシ−2−
オキソ−1,2,3,4−テトラヒドロキノリンを製造
する方法を提供することを目的とする。DISCLOSURE OF THE INVENTION The present invention provides an industrially safe, simple and inexpensive 6-hydroxy-2-yield with good yield.
An object of the present invention is to provide a method for producing oxo-1,2,3,4-tetrahydroquinoline.
【0013】[0013]
【課題を解決するための手段】本発明者らは上記の従来
の製造方法における問題点を解決するために研究を重ね
た結果、安全で簡単に収率よく6−ヒドロキシ−2−オ
キソ−1,2,3,4−テトラヒドロキノリンを製造す
る方法を見い出し、本発明を完成した。すなわち、本発
明は、下記一般式(II)で表されるN−(4−置換-ベ
ンゾ)−3−クロロプロピオニルアミドを均一化剤の存
在下でルイス酸と反応させる工程を含む一般式(I)で
表される6−ヒドロキシ−2−オキソ−1,2,3,4
−テトラヒドロキノリンの製造方法を提供する。Means for Solving the Problems The inventors of the present invention have conducted studies to solve the above-mentioned problems in the conventional production method, and as a result, have found that 6-hydroxy-2-oxo-1 is safe, easily and in good yield. The present invention was completed by finding a method for producing 2,2,3,4-tetrahydroquinoline. That is, the present invention provides a general formula (N) comprising reacting N- (4-substituted-benzo) -3-chloropropionylamide represented by the following general formula (II) with a Lewis acid in the presence of a homogenizing agent. 6-hydroxy-2-oxo-1,2,3,4 represented by I)
-To provide a method for producing tetrahydroquinoline.
【化10】 Embedded image
【化11】 (式中、Rは水素原子、メチル基またはエチル基であ
る。)Embedded image (In the formula, R is a hydrogen atom, a methyl group or an ethyl group.)
【0014】本発明の製造方法における反応工程は下記
反応式で表される。The reaction step in the production method of the present invention is represented by the following reaction formula.
【化12】 (式中、Rは水素原子、メチル基またはエチル基であ
る。)Embedded image (In the formula, R is a hydrogen atom, a methyl group or an ethyl group.)
【0015】本発明における「均一化剤」とは、2種類
以上の反応物質を均一に混濁させ、溶融状態での反応時
の問題点である不均一な反応進行を改善し、熱伝達の減
少を緩和させる物質である。換言すれば、未反応物をな
くし、より低い温度で均一に反応を進行させる溶剤であ
る。本発明の製造方法において用いられる均一化剤とし
ては、デカヒドロナフタレン;ジフェニルエーテル,イ
ソアミルエーテル、ベンジルエチルエーテル,ジグリ
ム,トリグリムなどの高沸点のエーテル化合物;または
β-ピネン、リモネン,テトラリンなどの炭化水素化合
物が挙げられる。これらのうち、デカヒドロナフタレン
が最も好ましい。The term "homogenizing agent" in the present invention means that two or more kinds of reactants are uniformly turbid to improve uneven reaction progress which is a problem at the time of reaction in a molten state, and to reduce heat transfer. It is a substance that relaxes. In other words, it is a solvent that eliminates unreacted substances and allows the reaction to proceed uniformly at a lower temperature. Examples of the homogenizing agent used in the production method of the present invention include decahydronaphthalene; a high-boiling ether compound such as diphenyl ether, isoamyl ether, benzylethyl ether, diglyme, and triglyme; and a hydrocarbon such as β-pinene, limonene, and tetralin. Compounds. Of these, decahydronaphthalene is most preferred.
【0016】本発明の製造方法において用いられるルイ
ス酸触媒としては、塩化アルミニウム、塩化亜鉛または
四塩化チタニウムが挙げられ、特に塩化アルミニウムが
好ましく用いられる。反応は、一般式(II)の化合物に
対して、ルイス酸を2〜10モル、好ましくは3〜5モル、
均一化剤を1〜20ml/g、好ましくは1〜5ml/g使用し、0〜
200℃、好ましくは120〜150℃で、2〜18時間、好ましく
は6〜10時間行なわれる。Examples of the Lewis acid catalyst used in the production method of the present invention include aluminum chloride, zinc chloride and titanium tetrachloride, and aluminum chloride is particularly preferably used. In the reaction, the Lewis acid is used in an amount of 2 to 10 mol, preferably 3 to 5 mol, based on the compound of the general formula (II),
Use a homogenizing agent in an amount of 1 to 20 ml / g, preferably 1 to 5 ml / g.
The reaction is performed at 200 ° C., preferably 120 to 150 ° C., for 2 to 18 hours, preferably 6 to 10 hours.
【0017】反応生成物である一般式(I)の化合物
は、公知の方法、例えば、メタノールからの再結晶等に
より精製することができる。The compound of the general formula (I) as a reaction product can be purified by a known method, for example, recrystallization from methanol and the like.
【0018】出発物質である一般式(II)で表される化
合物は、一般式(III)の4−置換−アニリンを一般式
(IV)で表される3−クロロプロピオニルクロリドと反
応させることにより、高収率(97%)で得ることができ
る。The starting compound represented by the general formula (II) is prepared by reacting a 4-substituted aniline of the general formula (III) with 3-chloropropionyl chloride represented by the general formula (IV). , In high yield (97%).
【化13】 (式中、Rは水素原子、メチル基またはエチル基であ
る。)Embedded image (In the formula, R is a hydrogen atom, a methyl group or an ethyl group.)
【0019】この反応は、酢酸エチル、ジメチルホルム
アミド及びジメチルスルホキシドのような極性有機溶
媒、またはヘキサン、ベンゼンのような非極性有機溶媒
中、10〜30℃で1〜3時間行われる。この時、4−置換−
アニリンに対して、3−クロロプロピオニルクロリドを
1〜5モル、好ましくは1.2〜2モル、上記溶媒を5〜20ml/
g使用する。This reaction is carried out in a polar organic solvent such as ethyl acetate, dimethylformamide and dimethylsulfoxide or a non-polar organic solvent such as hexane and benzene at 10 to 30 ° C. for 1 to 3 hours. At this time, 4-substitution-
For aniline, 3-chloropropionyl chloride
1 to 5 mol, preferably 1.2 to 2 mol, the above solvent is 5 to 20 ml /
Use g.
【0020】得られた一般式(II)の化合物はイソプロ
パノールと水の混合液からの再結晶等公知の方法により
精製することができる。The obtained compound of the general formula (II) can be purified by a known method such as recrystallization from a mixed solution of isopropanol and water.
【0021】本発明の工程に従って製造された一般式
(I)の6−ヒドロキシ−2−オキソ−1,2,3,4
−テトラヒドロキノリンは血栓治療剤であるシロスタゾ
ルの合成中間体として有用である。The 6-hydroxy-2-oxo-1,2,3,4 of the general formula (I) prepared according to the process of the present invention
-Tetrahydroquinoline is useful as a synthetic intermediate for cilostazol, a therapeutic agent for thrombosis.
【0022】[0022]
【実施例】以下、本発明を実施例によりさらに詳しく説
明するが、本発明はこれらに限定されるものではない。EXAMPLES The present invention will be described in more detail with reference to the following Examples, but it should not be construed that the invention is limited thereto.
【0023】[実施例1] N−(4−ヒドロキシベン
ゾ)−3−クロロプロピオニルアミド(II)の製造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内に酢酸エチル1000ml及び4−ヒドロキシアニリン10
9.1g(1mol)を加えた。室温で酢酸エチル500mlで希釈し
た3-クロロプロピオニルクロリド190.5g(1.5mol)をフラ
スコ内にゆっくり滴下した後、反応液を1時間激しく撹
拌した。この反応液に飽和炭酸ナトリウム1000mlを加え
塩を完全に溶解させ、有機層を分離し、水500mlで洗浄
した。分離した有機層を硫酸マグネシウムを用いて乾燥
し、減圧蒸留により溶媒を除去した。残査をイソプロパ
ノールと水の混合液で結晶化させ、薄紫色のN−(4−
ヒドロキシベンゾ)−3−クロロプロピオニルアミド18
9.7g(95%)を得た。 融点:127℃〜129℃(実測:128℃〜129℃)。 IR:νmax(cm-1) 3300 (N-H strech), 3200 (O-H strec
h), 1655 (C=O strech),	1561, 1508, 1412, 1264,
1200, 980, 839。1 H NMR: δ 2.75 (2H, t, ClCH2CH2 CO-), 3.86 (2H,
t, ClCH2 CH2CO-), 6.67〜7.38 (4H, q, Aromatic CH
-), 9.17 (1H, s, HOPh-), 9.79 (1H, s, ClCH2CH2CONH
-)。Example 1 N- (4-hydroxybenz)
Production of zo) -3-chloropropionylamide (II) A flask containing a magnetic stirrer under a nitrogen stream
1,000 ml of ethyl acetate and 4-hydroxyaniline 10
9.1 g (1 mol) were added. Dilute with 500 ml of ethyl acetate at room temperature
190.5 g (1.5 mol) of 3-chloropropionyl chloride
After slowly dropping the solution, the reaction solution is vigorously stirred for 1 hour.
Stirred. 1000 ml of saturated sodium carbonate was added to the reaction solution.
Dissolve the salt completely, separate the organic layer and wash with 500 ml of water
did. Dry the separated organic layer using magnesium sulfate
Then, the solvent was removed by distillation under reduced pressure. The residue is isopropa
Crystallized with a mixture of phenol and water, light purple N- (4-
(Hydroxybenzo) -3-chloropropionylamide 18
9.7 g (95%) were obtained. Melting point: 127-129 [deg.] C (actual measurement: 128-129 [deg.] C). IR: νmax (cm-1) 3300 (N-H strech), 3200 (O-H strec)
h), 1655 (C = O strech), 	 1561, 1508, 1412, 1264,
1200, 980, 839.1 H NMR: δ 2.75 (2H, t, ClCHTwoCH 2 CO-), 3.86 (2H,
t, ClCH 2 CHTwoCO-), 6.67 to 7.38 (4H, q, Aromatic CH
-), 9.17 (1H, s,HOPh-), 9.79 (1H, s, ClCHTwoCHTwoCONH
-).
【0024】[実施例2] N−(4−メトキシベン
ゾ)−3−クロロプロピオニルアミド(II)の製造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内に酢酸エチル1000ml及び4−メトキシアニリン123.
2g(1mol)を加えた。酢酸エチル500mlで希釈した3-クロ
ロプロピオニルクロリド190.5g(1.5mol)を室温でフラス
コ内にゆっくり滴下した後、反応液を1時間激しく撹拌
した。この反応液に飽和炭酸ナトリウム1000mlを加え塩
を完全に溶解させ、有機層を分離し、水500mlで洗浄し
た。分離した有機層を硫酸マグネシウムを用いて乾燥さ
せ、減圧蒸留により溶媒を除去した。残査をイソプロパ
ノールと水の混合液で結晶化させ、薄紫色のN−(4−
メトキシベンズ)−3−クロロプロピオニルアミド20
7.3g(97%)を得た。 融点:120℃〜122℃(実測:121℃〜122℃)。 IR:νmax(cm-1) 3275 (N-H strech), 1653 (C=O stre
ch), 1605, 1549, 1512,1301, 1244, 1030, 929, 829。1 H NMR: δ 2.79 (2H, t, ClCH2CH2 CO-), 3.79 (3H,
s, CH3 OPh-), 3.88 (2H,t, ClCH2 CH2CO-), 6.85〜7.43
(4H, q, Aromatic CH-), 7.43 (1H, s, ClCH2CH 2CONH
-)。Example 2 N- (4-methoxybenz)
Production of zo) -3-chloropropionylamide (II) A flask containing a magnetic stirrer under a nitrogen stream
1000 ml of ethyl acetate and 4-methoxyaniline 123.
2 g (1 mol) were added. 3-chlorodiluted with 500 ml of ethyl acetate
Add 190.5 g (1.5 mol) of lopropionyl chloride at room temperature
After slowly dripping into the container, vigorously stir the reaction solution for 1 hour
did. 1000 ml of saturated sodium carbonate was added to this reaction solution, and salt was added.
Was completely dissolved, the organic layer was separated and washed with 500 ml of water.
Was. The separated organic layer is dried using magnesium sulfate.
And the solvent was removed by distillation under reduced pressure. The residue is isopropa
Crystallized with a mixture of phenol and water, light purple N- (4-
Methoxybenz) -3-chloropropionylamide 20
7.3 g (97%) were obtained. Melting point: 120-122 ° C (actual measurement: 121-122 ° C). IR: νmax (cm-1) 3275 (N-H strech), 1653 (C = O stre
ch), 1605, 1549, 1512,1301, 1244, 1030, 929, 829.1 H NMR: δ 2.79 (2H, t, ClCHTwoCH 2 CO-), 3.79 (3H,
s, CH 3 OPh-), 3.88 (2H, t, ClCH 2 CHTwoCO-), 6.85-7.43
(4H, q, Aromatic CH-), 7.43 (1H, s, ClCHTwoCH TwoCONH
-).
【0025】[実施例3] N−(4−エトキシベン
ゾ)−3−クロロプロピオニルアミド(II)の製造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内に酢酸エチル1000ml及び4−エトキシアニリン137.
2g(1mol)を加えた。酢酸エチル500mlで希釈した3−ク
ロロプロピオニルクロリド190.5g(1.5mol)を室温でフラ
スコ内にゆっくり滴下した後、反応液を1時間激しく撹
拌した。この反応液に飽和炭酸ナトリウム1000mlを加え
塩を完全に溶解させた後、有機層を分離し、水500mlで
洗浄した。分離した有機層を硫酸マグネシウムを用いて
乾燥させ、減圧蒸留により溶媒を除去した。残査をイソ
プロパノールと水の混合液中で結晶化させ、薄紫色のN
−(4−エトキシベンゾ)−3−クロロプロピオニルア
ミド214.0g(94%)を得た。 融点:117℃〜119℃(実測:118℃〜119℃)。 IR: νmax (cm-1) 3280 (N-H strech), 1653 (C=O st
rech), 1605, 1548, 1511, 1308, 1241, 1047, 931, 83
0。1 H NMR: δ1.40 (3H, t, CH3 CH2OPh-), 2.77 (2H, t,
ClCH2CH2 CO-), 3.86 (2H, t, ClCH2 CH2CO-), 4.01 (2
H, q, CH3CH2 OPh-), 6.82〜7.40 (4H, q, Aromatic CH
-), 7.56 (1H, s, ClCH2CH2CONH-)。Example 3 Production of N- (4-ethoxybenzo) -3-chloropropionylamide (II) 1000 ml of ethyl acetate and 4-ethoxyaniline 137 were placed in a flask containing a magnetic stirrer under a nitrogen stream. .
2 g (1 mol) were added. After 190.5 g (1.5 mol) of 3-chloropropionyl chloride diluted with 500 ml of ethyl acetate was slowly dropped into the flask at room temperature, the reaction solution was vigorously stirred for 1 hour. After adding 1000 ml of saturated sodium carbonate to the reaction solution to completely dissolve the salt, the organic layer was separated and washed with 500 ml of water. The separated organic layer was dried using magnesium sulfate, and the solvent was removed by distillation under reduced pressure. The residue was crystallized in a mixture of isopropanol and water to give a light purple N
214.0 g (94%) of-(4-ethoxybenzo) -3-chloropropionylamide were obtained. Melting point: 117-119 ° C (actual measurement: 118-119 ° C). IR: νmax (cm -1 ) 3280 (NH strech), 1653 (C = O st
rech), 1605, 1548, 1511, 1308, 1241, 1047, 931, 83
0. 1 H NMR: δ1.40 (3H, t, CH 3 CH 2 OPh-), 2.77 (2H, t,
ClCH 2 C H 2 CO-), 3.86 (2H, t, ClC H 2 CH 2 CO-), 4.01 (2
H, q, CH 3 C H 2 OPh-), 6.82 to 7.40 (4H, q, Aromatic C H
-), 7.56 (1H, s, ClCH 2 CH 2 CON H- ).
【0026】[実施例4] 6−ヒドロキシ−2−オキ
ソ−1,2,3,4−テトラヒドロキノリン(I)の製
造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内にデカヒドロナフタレン500ml、N−(4−ヒドロ
キシベンゾ)−3−クロロプロピオニルアミド199.1g(1
mol)及び塩化アルミニウム667g(5mol)を加え、室温より
ゆっくり温度を上昇させ150℃で8時間撹拌し反応させ
た。生成した固体を5℃に冷却し、水(1000ml)とクロロ
ホルム(1000ml)を加え激しく撹拌し、粉砕した。生成物
を濾取し、水及びクロロホルムで洗浄した。濾取した生
成物を真空乾燥させ、6−ヒドロキシ−2−オキソ−
1,2,3,4−テトラヒドロキノリン146.9g(90%)を
得た。 融点:235℃〜237℃(実測:236℃〜237℃)。 IR: νmax(cm-1) 3315 (N-H strech), 3200 (O-H str
ech), 1649 (C=O strech), 1502, 1392, 1287, 1252, 1
151, 1116, 963, 813, 777。1 H NMR: δ2.35 (2H, t, -CH2CH2 CO-), 2.76 (2H, t, -
CH2 CH2CO-), 6.51〜6.66(3H, m, Aromatic CH-), 9.00
(1H, s, HOPh-), 9.79 (1H, s, -CH2CH2CONH-)。Example 4 Production of 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline (I) Under a nitrogen stream, 500 ml of decahydronaphthalene was placed in a flask containing a magnetic stirrer. 199.1 g of N- (4-hydroxybenzo) -3-chloropropionylamide (1
mol) and 667 g (5 mol) of aluminum chloride, the temperature was slowly raised from room temperature, and the mixture was stirred and reacted at 150 ° C. for 8 hours. The resulting solid was cooled to 5 ° C., water (1000 ml) and chloroform (1000 ml) were added, and the mixture was vigorously stirred and pulverized. The product was collected by filtration and washed with water and chloroform. The product collected by filtration was dried in vacuo and 6-hydroxy-2-oxo-
146.9 g (90%) of 1,2,3,4-tetrahydroquinoline were obtained. Melting point: 235-237 [deg.] C (actual measurement: 236-237 [deg.] C). IR: νmax (cm -1 ) 3315 (NH strech), 3200 (OH str
ech), 1649 (C = O strech), 1502, 1392, 1287, 1252, 1
151, 1116, 963, 813, 777. 1 H NMR: δ 2.35 (2H, t, -CH 2 C H 2 CO-), 2.76 (2H, t,-
C H 2 CH 2 CO-), 6.51 to 6.66 (3H, m, Aromatic C H- ), 9.00
(1H, s, H OPh-), 9.79 (1H, s, -CH 2 CH 2 CON H- ).
【0027】[実施例5] 6−ヒドロキシベンゾ−2
−オキソ−1,2,3,4−テトラヒドロキノリン
(I)の製造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内にデカヒドロナフタレン500ml、N−(4−メトキ
シベンゾ)−3−クロロプロピオニルアミド213.7g(1mo
l)及び塩化アルミニウム667g(5mol)を加えた。室温より
ゆっくり温度を上昇させ反応液を150℃で8時間撹拌し反
応させた。生成した固体を5℃に冷却し、水(1000ml)と
クロロホルム(1000ml)を加えて激しく撹拌し粉砕した。
生成物を濾取し、水及びクロロホルムで洗浄した。濾取
した生成物を真空乾燥させ、6−ヒドロキシ−2−オキ
ソ−1,2,3,4−テトラヒドロキノリン155.0g(95
%)を得た。融点、IR及び1H NMRのデータは実施例4と
同様である。Example 5 6-Hydroxybenzo-2
Preparation of -oxo-1,2,3,4-tetrahydroquinoline (I) 500 ml of decahydronaphthalene and N- (4-methoxybenzo) -3-chloropropionyl in a flask containing a magnetic stirrer under a nitrogen stream. Amide 213.7g (1mo
l) and 667 g (5 mol) of aluminum chloride were added. The temperature was slowly raised from room temperature, and the reaction solution was stirred at 150 ° C. for 8 hours to react. The resulting solid was cooled to 5 ° C., water (1000 ml) and chloroform (1000 ml) were added, and the mixture was vigorously stirred and pulverized.
The product was collected by filtration and washed with water and chloroform. The product obtained by filtration was dried in vacuo, and 155.0 g of 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline (95%
%). Melting point, IR and 1 H NMR data are the same as in Example 4.
【0028】[実施例6] 6−ヒドロキシ−2−オキ
ソ−1,2,3,4−テトラヒドロキノリン(I)の製
造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内にデカヒドロナフタレン500ml、N−(4−メトキ
シベンゾ)−3−クロロプロピオニルアミド227.7g(1mo
l)及び塩化アルミニウム667g(5mol)を加えた後、室温よ
りゆっくり温度を上昇させ150℃で8時間撹拌し反応させ
た。生成した固体を5℃に冷却し、水(1000ml)とクロロ
ホルム(1000ml)を加え、激しく撹拌し、粉砕した。生成
物を濾取し、水及びクロロホルムで洗浄した。濾取した
生成物を真空乾燥させ、6−ヒドロキシ−2−オキソ−
1,2,3,4−テトラヒドロキノリン145.2g(89%)を
得た。融点、IR及び1H NMRのデータは実施例4と同様で
ある。Example 6 Production of 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline (I) Under a nitrogen stream, 500 ml of decahydronaphthalene was placed in a flask containing a magnetic stirrer. 227.7 g of N- (4-methoxybenzo) -3-chloropropionylamide (1mo
After l) and 667 g (5 mol) of aluminum chloride were added, the temperature was slowly raised from room temperature, and the mixture was stirred and reacted at 150 ° C. for 8 hours. The resulting solid was cooled to 5 ° C., water (1000 ml) and chloroform (1000 ml) were added, stirred vigorously and pulverized. The product was collected by filtration and washed with water and chloroform. The product collected by filtration was dried in vacuo and 6-hydroxy-2-oxo-
145.2 g (89%) of 1,2,3,4-tetrahydroquinoline were obtained. Melting point, IR and 1 H NMR data are the same as in Example 4.
【0029】[実施例7] 6−ヒドロキシ−2−オキ
ソ−1,2,3,4−テトラヒドロキノリン(I)の製
造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内にデカヒドロナフタレン500ml、N−(4−メトキ
シベンゾ)−3−クロロプロピオニルアミド213.7g(1mo
l)及び塩化亜鉛681.5g(5mol)を加えた。室温よりゆっく
り温度を上昇させ、150℃で12時間反応液を撹拌し反応
させた。生成した固体を5℃に冷却し、水(1000ml)とク
ロロホルム(1000ml)を加えて激しく撹拌し粉砕した。生
成物を濾取し、水及びクロロホルムで洗浄した。濾取し
た生成物を真空乾燥させ、6−ヒドロキシ−2−オキソ
−1,2,3,4−テトラヒドロキノリン143.6g(88%)
を得た。融点、IR及び1H NMRのデータは実施例4と同様
である。Example 7 Production of 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline (I) Under a nitrogen stream, 500 ml of decahydronaphthalene was placed in a flask containing a magnetic stirrer. 213.7 g of N- (4-methoxybenzo) -3-chloropropionylamide (1mo
l) and 681.5 g (5 mol) of zinc chloride were added. The temperature was slowly raised from room temperature, and the reaction solution was stirred at 150 ° C. for 12 hours to react. The resulting solid was cooled to 5 ° C., water (1000 ml) and chloroform (1000 ml) were added, and the mixture was vigorously stirred and pulverized. The product was collected by filtration and washed with water and chloroform. The product obtained by filtration was dried in vacuo and 143.6 g (88%) of 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline.
I got Melting point, IR and 1 H NMR data are the same as in Example 4.
【0030】[実施例8] 6−ヒドロキシ−2−オキ
ソ−1,2,3,4−テトラヒドロキノリン(I)の製
造 窒素気流下でマグネティックスタ−ラーを入れたフラス
コ内にデカヒドロナフタレン500ml、N-(4-メトキシベン
ゾ)-3-クロロプロピオニルアミド213.7g(1mol)及び四塩
化チタニウム948.5g(5mol)を加えた。室温よりゆっくり
温度を上昇させ、反応液を150℃で16時間撹拌し反応さ
せた。生成した固体を5℃に冷却し、水(1000ml)とクロ
ロホルム(1000ml)を加えて激しく撹拌し粉砕した。生成
物を濾取し、水及びクロロホルムで洗浄した。濾取した
生成物を真空乾燥させ、6−ヒドロキシ−2−オキソ−
1,2,3,4−テトラヒドロキノリン133.8g(82%)を
得た。融点、IR及び1H NMRのデータは実施例4と同様で
ある。Example 8 Production of 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline (I) Under a nitrogen stream, 500 ml of decahydronaphthalene was placed in a flask containing a magnetic stirrer. 213.7 g (1 mol) of N- (4-methoxybenzo) -3-chloropropionylamide and 948.5 g (5 mol) of titanium tetrachloride were added. The temperature was slowly raised from room temperature, and the reaction solution was stirred at 150 ° C. for 16 hours to react. The resulting solid was cooled to 5 ° C., water (1000 ml) and chloroform (1000 ml) were added, and the mixture was vigorously stirred and pulverized. The product was collected by filtration and washed with water and chloroform. The product collected by filtration was dried in vacuo and 6-hydroxy-2-oxo-
133.8 g (82%) of 1,2,3,4-tetrahydroquinoline were obtained. Melting point, IR and 1 H NMR data are the same as in Example 4.
【0031】[0031]
【発明の効果】本発明によれば、6−ヒドロキシ−2−
オキソ−1,2,3,4−テトラヒドロキノリンを簡単
に、収率よく製造することができる。また、危険な副産
物を生じることがないので、工業的な生産に容易に応用
することができる。本発明によって得られる6−ヒドロ
キシ−2−オキソ−1,2,3,4−テトラヒドロキノ
リンは血栓治療剤であるシロスタゾルの合成中間体とし
て有用である。According to the present invention, 6-hydroxy-2-
Oxo-1,2,3,4-tetrahydroquinoline can be easily produced with high yield. In addition, since no dangerous by-products are generated, it can be easily applied to industrial production. 6-Hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline obtained by the present invention is useful as a synthetic intermediate for cilostazol, a therapeutic agent for thrombosis.
フロントページの続き (71)出願人 599053001 535−3, Daeyang−ri, Y angkam−myun, Hwasun g−gun,Kyonggi−do 445 −930, Korea (72)発明者 パーク イン キュ 大韓民国 キョンギド スワン ウェオン セオング グーンドン 462 サムワン アパートメント 2−805 (72)発明者 シン サン フーン 大韓民国 ソウル カンドング アムサド ン 414−2 カンドン アパートメント 7−201 Fターム(参考) 4C031 EA11 Continuation of the front page (71) Applicant 599053001 535-3, Daeyang-ri, Yangkam-myun, Hwasun g-gun, Kyonggi-do 445-930, Korea (72) Inventor Park In Kyu South Korea Gyeonggido Swan Weong Seong Goon 462 Samwan Apartment 2-805 (72) Inventor Shin Sang Hoon South Korea Seoul Kangdong Amsadon 414-2 Kangdong Apartment 7-201 F-term (reference) 4C031 EA11
Claims (8)
置換-ベンゾ)−3−クロロプロピオニルアミドを均一化
剤の存在下でルイス酸と反応させる工程を含む、一般式
(I)で表される6−ヒドロキシ−2−オキソ−1,
2,3,4−テトラヒドロキノリンの製造方法。 【化1】 【化2】 (式中、Rは水素原子、メチル基またはエチル基であ
る。)1. N- (4-) represented by the following general formula (II)
Reacting the substituted-benzo) -3-chloropropionylamide with a Lewis acid in the presence of a homogenizing agent, the method comprising reacting 6-hydroxy-2-oxo-1,
A method for producing 2,3,4-tetrahydroquinoline. Embedded image Embedded image (In the formula, R is a hydrogen atom, a methyl group or an ethyl group.)
−ベンゾ)−3−クロロプロピオニルアミドが溶媒中で
一般式(III)で表される4−置換−アニリンと一般式
(IV)で表される3−クロロプロピオニルクロリドを反
応させて得られる、請求項1に記載の6−ヒドロキシ−
2−オキソ−1,2,3,4−テトラヒドロキノリンの
製造方法。 【化3】 (式中、Rは水素原子、メチル基またはエチル基であ
る。) 【化4】 2. An N- (4-substituted-benzo) -3-chloropropionylamide represented by the general formula (II) is reacted with a 4-substituted-aniline represented by the general formula (III) in a solvent. The 6-hydroxy- according to claim 1, which is obtained by reacting 3-chloropropionyl chloride represented by (IV).
A method for producing 2-oxo-1,2,3,4-tetrahydroquinoline. Embedded image (In the formula, R is a hydrogen atom, a methyl group or an ethyl group.)
ェニルエーテル、イソアミルエーテル、ベンジルエチル
エーテル、ジグリム及びトリグリムよりなる群から選択
される高沸点のエーテル化合物;またはβ-ピネン、リ
モネン、テトラリンよりなる群から選択される炭化水素
化合物である、請求項1に記載の6−ヒドロキシ−2−
オキソ−1,2,3,4−テトラヒドロキノリンの製造
方法。3. The homogenizing agent is decahydronaphthalene; a high boiling ether compound selected from the group consisting of diphenyl ether, isoamyl ether, benzylethyl ether, diglyme and triglyme; or from the group consisting of β-pinene, limonene and tetralin. 6. 6-Hydroxy-2- according to claim 1, which is a selected hydrocarbon compound.
A method for producing oxo-1,2,3,4-tetrahydroquinoline.
または四塩化チタニウムである、請求項1に記載の6−
ヒドロキシ−2−オキソ−1,2,3,4−テトラヒド
ロキノリンの製造方法。4. The compound of claim 1, wherein the Lewis acid is aluminum chloride, zinc chloride or titanium tetrachloride.
A method for producing hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline.
る、請求項1に記載の6−ヒドロキシ−2−オキソ−
1,2,3,4−テトラヒドロキノリンの製造方法。5. The 6-hydroxy-2-oxo- according to claim 1, wherein the reaction is carried out at 0 ° C. to 200 ° C. for 2 to 18 hours.
A method for producing 1,2,3,4-tetrahydroquinoline.
ニリンと一般式(IV)で表される3−クロロプロピオニ
ルクロリドとの反応において、溶媒が酢酸エチル、ジメ
チルホルムアミド、ジメチルスルホキシド、ヘキサン及
びベンゼンよりなる群から選択される請求項2に記載の
6−ヒドロキシ−2−オキソ−1,2,3,4−テトラ
ヒドロキノリンの製造方法。6. A reaction between a 4-substituted-aniline represented by the general formula (III) and 3-chloropropionyl chloride represented by the general formula (IV), wherein a solvent is ethyl acetate, dimethylformamide, dimethylsulfoxide, The method for producing 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline according to claim 2, which is selected from the group consisting of hexane and benzene.
ニリンと一般式(IV)で表される3−クロロプロピオニ
ルクロリドとの反応が5℃〜100℃で行われる、請求項2
に記載の6−ヒドロキシ−2−オキソ−1,2,3,4
−テトラヒドロキノリンの製造方法。7. The reaction between a 4-substituted-aniline represented by the general formula (III) and 3-chloropropionyl chloride represented by the general formula (IV) is performed at 5 ° C. to 100 ° C.
6-hydroxy-2-oxo-1,2,3,4
-A method for producing tetrahydroquinoline.
より6−ヒドロキシ−2−オキソ−1,2,3,4−テ
トラヒドロキノリンを製造する工程及び得られた6−ヒ
ドロキシ−2−オキソ−1,2,3,4−テトラヒドロ
キノリンを5−ハロブチル−1−シクロヘキシルテトラ
ゾルと反応させる工程を含む、シロスタゾルの製造方
法。8. A process for producing 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline by the method according to any one of claims 1 to 7, and 6-hydroxy-2- obtained. A method for producing cilostazol, comprising the step of reacting oxo-1,2,3,4-tetrahydroquinoline with 5-halobutyl-1-cyclohexyltetrazol.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1999-4469 | 1999-02-09 | ||
KR1019990004469A KR100302346B1 (en) | 1999-02-09 | 1999-02-09 | A method of preparing 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2000229944A true JP2000229944A (en) | 2000-08-22 |
JP4173599B2 JP4173599B2 (en) | 2008-10-29 |
Family
ID=19573885
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP10801699A Expired - Lifetime JP4173599B2 (en) | 1999-02-09 | 1999-04-15 | Process for producing 6-hydroxy-2-oxo-1,2,3,4-tetrahydroquinoline |
Country Status (2)
Country | Link |
---|---|
JP (1) | JP4173599B2 (en) |
KR (1) | KR100302346B1 (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6825214B2 (en) | 2000-08-14 | 2004-11-30 | Teva Pharmaceutical Industries, Ltd. | Substantially pure cilostazol and processes for making same |
US7825251B2 (en) | 2001-05-02 | 2010-11-02 | Otsuka Pharmaceutical Co., Ltd. | Process for producing carbostyril derivatives |
EP2527336A1 (en) | 2007-04-25 | 2012-11-28 | Concert Pharmaceuticals Inc. | Deuterated analogues of cilostazol |
CN105111190A (en) * | 2015-09-17 | 2015-12-02 | 浙江金立源药业有限公司 | Method for synthesizing cilostazol |
CN107325078A (en) * | 2017-07-17 | 2017-11-07 | 烟台万润药业有限公司 | A kind of preparation method of Cilostazol |
-
1999
- 1999-02-09 KR KR1019990004469A patent/KR100302346B1/en active IP Right Grant
- 1999-04-15 JP JP10801699A patent/JP4173599B2/en not_active Expired - Lifetime
Cited By (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7064208B2 (en) | 2000-03-20 | 2006-06-20 | Teva Pharmaceutical Industries, Ltd. | Substantially pure cilostazol and processes for making same |
US7067669B2 (en) | 2000-03-20 | 2006-06-27 | Teva Pharmaceutical Industries, Ltd. | Substantially pure cilostazol and processes for making same |
US6825214B2 (en) | 2000-08-14 | 2004-11-30 | Teva Pharmaceutical Industries, Ltd. | Substantially pure cilostazol and processes for making same |
US7825251B2 (en) | 2001-05-02 | 2010-11-02 | Otsuka Pharmaceutical Co., Ltd. | Process for producing carbostyril derivatives |
EP2527336A1 (en) | 2007-04-25 | 2012-11-28 | Concert Pharmaceuticals Inc. | Deuterated analogues of cilostazol |
CN105111190A (en) * | 2015-09-17 | 2015-12-02 | 浙江金立源药业有限公司 | Method for synthesizing cilostazol |
CN107325078A (en) * | 2017-07-17 | 2017-11-07 | 烟台万润药业有限公司 | A kind of preparation method of Cilostazol |
CN107325078B (en) * | 2017-07-17 | 2020-01-07 | 烟台万润药业有限公司 | Preparation method of cilostazol |
Also Published As
Publication number | Publication date |
---|---|
KR100302346B1 (en) | 2001-09-22 |
JP4173599B2 (en) | 2008-10-29 |
KR20000055712A (en) | 2000-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH0730031B2 (en) | Process for producing 2-pyrazolin-5-ones | |
JPH05208978A (en) | Method for aroylating 5-position of 1,2-dihydro-3h-pyrrolo(1,2-alpha)pyrrole-1-carboxyic ester | |
JP2000229944A (en) | Production of 6-hydroxy-2-oxo-1,2,3,4-terrahydroquinoline | |
US4560692A (en) | 4-Piperidino-2-phenylquinolines | |
KR0130975B1 (en) | Method for the preparation of herbicidal o-carboxyarylimidazolinone compounds | |
WO2008077305A1 (en) | Quinoline compounds, intermediates, prepartion methods and uses thereof | |
JPS63179856A (en) | Production of quinolonecarboxylic acid derivative and intermediate thereof | |
HU204512B (en) | New process for producing quinoline-carboxylic acid derivatives | |
AU670708B2 (en) | Palladium catalyzed vinylic substitution reactions with 2-substituted-pyridines | |
JPH0753711B2 (en) | Novel pyrrolinones and their production method | |
EP0273321A1 (en) | 7-Bromo-beta-carboline compound and method for producing same | |
GB2092130A (en) | 4-Oximino-1,2,3,4- tetrahydroquinoline Derivatives | |
JPS63502429A (en) | Amifloxacin intermediate | |
JP4374088B2 (en) | Novel 4,4-difluorobenzazepine ketal derivative and method for producing 4,4-difluorobenzazepin-5-one derivative via the same | |
EP0079740B1 (en) | Anthraniloyloxyalkanoates | |
JP4663105B2 (en) | Method for producing 2-sulfonyl-4-oxypyridine derivative | |
JPH0480020B2 (en) | ||
KR0134906B1 (en) | Intermediate compound of herbicidal | |
JP4194984B2 (en) | Phenylnaphthylimidazole compound | |
JPS5916878A (en) | Production of 2,4-dihydroxy-3-acetylquinoline | |
JPH0359065B2 (en) | ||
JPS647074B2 (en) | ||
JPS6051180A (en) | Preparation of 1,2,4-triazolin-5-one | |
JP2001510830A (en) | Method for preparing 1,3-diaza-spiro (4,4) non-1-en-4-one derivative and 1-cyano-1-acylaminocyclopentane intermediate | |
JPS63112580A (en) | Tetrahydropyrido(2,3-d)pyrimidine derivative |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20040427 |
|
RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20050420 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20071108 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20071108 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080204 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080207 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080306 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080311 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20080404 |
|
A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20080409 |
|
A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080507 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20080730 |
|
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20080814 |
|
R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110822 Year of fee payment: 3 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120822 Year of fee payment: 4 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20130822 Year of fee payment: 5 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
EXPY | Cancellation because of completion of term |